According to Nova one advisor, the global Nuclear Magnetic Resonance Spectroscopy market was valued at USD 657.1 million in 2021 and it is expected to hit around USD 1,025.3 million by 2030 with a CAGR of 5.1% during the forecast period 2022 to 2030.
According to Nova one advisor, the global Nuclear Magnetic Resonance Spectroscopy market was valued at USD 657.1 million in 2021 and it is expected to hit around USD 1,025.3 million by 2030 with a CAGR of 5.1% during the forecast period 2022 to 2030.
Get the Sample Copy of Report@ https://www.novaoneadvisor.com/report/sample/6797
Key Takeaways:
- By End-Use, the U.S. Nuclear Magnetic Resonance Spectroscopy market was valued at USD 187 million in 2021 and expected to witness growth at a CAGR of 4.9% from 2022 to 2030.
- By product, the instruments segment held the dominant share of the NMR spectroscopy industry, owing to the increasing demand by universities and research centers for high-field NMR spectroscopy
- The steadily increasing scope of the product has a significant impact on the market. For instance, solid-state NMR spectroscopy (SSNMR) is considered an analytical tool for drug characterization, hence propelling the market growth
- By type, the high-field NMR spectroscopy segment dominated the market in 2021, since it offers better sensitivity to the researchers
- By end-use, the academic segment held a larger share in 2021; numerous universities employ NMR analysis to enhance chemical identification in pharmaceutical and chemical industries
- North America held a substantial share in the global market in 2021 due to the presence of a large number of universities and increasing funding support by the government to enhance research infrastructure
- The Asia Pacific region is projected to grow considerably in the future, owing to the rising availability of raw materials and increasing biomedical research in the pharma and biotech industry
The rising need for metabolomics-based diagnosis, coupled with increasing usage in various fields, is anticipated to surge the growth of the market. Bruker offers nuclear magnetic resonance (NMR) spectroscopy solutions for multi-omics, tissue SpatialOMx, proteomics, functional structural biology, biomolecular condensates, and biopharma and applied.
The market for NMR spectroscopy witnessed incremental growth in 2021 and is anticipated to showcase a similar trend in the forecast period. The instrument demand from academic and university research centers is a significant contributor to the revenue. For instance, in June 2021, National Science Foundation announced an investment of USD 40 million to develop the Network for Advanced NMR (NAN) between the University of Georgia, UConn School of Medicine, and UW–Madison’s National Magnetic Resonance Facility at Madison.
Other determinants such as the rapidly expanding demand for generic medicine, technical improvements in healthcare, as well as government initiatives and grants in the nuclear magnetic resonance spectroscopy industry are also contributing to the market’s growth. In the U.S., government-funded - S10 Instrumentation Programs have been formed to support the purchase of instruments, including NMR spectroscopy. There are three active funding programs with June 2023 as the deadline. These programs range from USD 25,000 to USD 2,000,000.
The COVID-19 pandemic is anticipated to positively impact the demand for the product. However, supply shortages and accelerated prices of raw materials impacted the profitability of the players. The prices of key raw materials such as copper, steel, and metallic, used for superconductors, have risen over the last decade.
The increasing demand for cancer diagnostics is expected to majorly drive market growth in the coming years. Diagnosis for Parkinson’s disease, cancer, infectious diseases, and psychiatric disorders, has been investigated with the use of NMR spectroscopy. For instance, in January 2022, a study was conducted at the University of Oxford to develop a new blood test, through NMR metabolomics, that can identify a range of cancers.
On the other hand, this is a niche market with limited players. Additionally, NMR spectroscopy is considered to be bulky and expensive, as its cost ranges from around a few hundred thousand dollars for 400 MHz, to millions for higher field magnets. Additionally, the requirement of high-field magnets, filled with cryogenic fluids regularly, and routine maintenance of electronics and probes increases the cost.
Report Scope of the Nuclear Magnetic Resonance Spectroscopy Market
| Report Coverage | Details |
| Market Size | US$ 1,025.3 million by 2030 |
| Growth Rate | CAGR of 5.1% from 2022 to 2030 |
| Largest Market | North America |
| Fastest Growing Market | Asia Pacific |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
| Segments Covered | Type, product, end-use and Region |
Immediate Delivery Available | Buy this Premium Research Report@ https://www.novaoneadvisor.com/report/checkout/6797
Type Insights
The high-field segment held the dominant share of the market at 87.6% in 2021, owing to factors such as better sensitivity and resolution. The increased strength of nuclear magnetic resonance spectroscopy has an immense impact on various fields, such as material science, structural biology, and imaging. For instance, in July 2021, Bruker announced that it had received orders for its new Ascend Evo 1.0 GHz NMR magnet, which is a compact instrument for clinical research and structural biology applications in single-story laboratories.
Similarly, in June 2022, UK Research and Innovation (UKRI) announced its plans to invest USD 576.61 million for over 30 research infrastructure projects. This also includes USD 19.18 million investment in securing a 1.2 GHz NMR spectrometer. The authority stated that the use of NMR spectroscopy is anticipated to stay competitive across biological, health, materials, and environmental science spaces.
Furthermore, it has been observed that major demand for high-field NMR spectroscopy is from research centers and universities. For illustration, RIKEN Center for Biosystems Dynamics Research in Japan raised the requirement for high-field NMR spectroscopy to understand the dynamic structures of biomolecules in the sample and to assess the relationship between biological functions and dynamical structures.
End-Use Insights
The pharma and biotech companies segment is poised to advance at the highest CAGR of 5.7%. However, the academic segment captured the highest revenue share of the NMR spectroscopy market in 2021. The increasing initiatives by universities to establish in-house NMR spectroscopy facilities as a competitive advantage, with the financial support of the government, is considered to be a key growth determinant of this market. Facilities such as Universitat Politècnica de Catalunya, University of Oxford, and Universidad Complutense Madrid, have set up Nuclear Magnetic Resonance Centers for research.
Furthermore, various device manufacturers and distributors collaborate with universities for research and development in the field of diagnostics. For instance, Lab Manager has multiple collaborations with academic and research centers, including Oxford University and Mayo Clinic labs, to develop a clinical diagnostic test using NMR technology. These factors are anticipated to increase the adoption of NMR spectroscopy among hospitals and clinics.
Product Insights
The instruments segment is projected to expand at 4.9% CAGR during 2022-2030. Innovative development in instruments that extends their use is a significant growth factor for this market. For instance, in July 2022, Bruker announced the launch of a new assay for research on long COVID-19. The test involves an Avance IVDr NMR spectroscopy system that can assess various biological mechanisms within 20 minutes.
The product segment is bifurcated into instruments and consumables. The consumables segment is anticipated to witness the fastest growth during the forecast period, owing to the increasing frequency of usage by biotech and pharmaceutical companies for clinical research. For instance, JEOL Ltd. offers a range of probes in liquid and solid states for numerous applications, and each probe is supported by the company’s software.
Regional Insights
Europe dominated the regional market with a share of 38.11% in 2021. This major share can be attributed to an increasing number of funders in biomedical research, the strong presence of universities with advanced research facilities, and the escalating usage of technological developments through strategic initiatives in the region.
The Asia Pacific is projected to be the fastest-growing region due to substantial developments by India and Japan in the technological integration of the NMR spectroscopy technique. However, the tariff imposed by Chinese regulators on various products is anticipated to restrain the regional growth of the product. The high tariff accelerates the cost and results in lower gross margin profit for manufacturers.
Some of the prominent players in the Nuclear Magnetic Resonance Spectroscopy Market include:
- JEOL Ltd.
- Thermo Fisher Scientific Inc.
- Bruker
- Magritek
- Oxford Instruments
- Nanalysis Corp.
- Anasazi Instruments, Inc.
- QOneTec
- Advanced Magnetic Resonance Limited
Segments Covered in the Report
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2017 to 2030. For this study, Nova one advisor, Inc. has segmented the global Nuclear Magnetic Resonance Spectroscopy market
- Product
- Instruments
- Consumables
- Type
- Low-field NMR Spectroscopy
- High-field NMR Spectroscopy
- End-use
- Academic
- Pharmaceutical & Biotech Companies
- Agriculture & Food
- Chemical Industry
- Others
Report Objectives
- To define, describe, and forecast the global Nuclear Magnetic Resonance Spectroscopy market based on product, technique, methodology, category, and region
- To provide detailed information regarding the major factors influencing the market growth (drivers, restraints, growth opportunities, and challenges)
- To strategically analyze micromarkets1 with respect to individual growth trends, future prospects, and contributions to the overall market
- To analyze the opportunities in the market for key stakeholders and provide details of the competitive landscape for major market leaders
- To forecast the size of the market segments with respect to five main regions—North America (the US and Canada), Europe (Germany, the UK, France, Italy, Spain, and Rest of Europe), Asia Pacific (Japan, China, India, Australia, South Korea, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and the Middle East and Africa
- To profile the key market players and comprehensively analyze their market shares and core competencies2
- To track and analyze competitive developments such as mergers and acquisitions, new product developments, partnerships, agreements, collaborations, and expansions in the global Nuclear Magnetic Resonance Spectroscopy market
For Purchase Inquiry@ https://www.novaoneadvisor.com/report/checkout/6797
About Us
Nova One Advisor is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Nova One Advisor has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings.
You can place an order or ask any questions, please feel free to sales@novaoneadvisor.com| +1 9197 992 333